Aslihan Dincer, PhD, FACMG Associate Clinical Laboratory Director of Women’s Health, Natera Inc.
Dr. Aslihan Dincer is a board-certified clinical molecular geneticist and is the Associate Clinical Laboratory Director of Women’s Health at Natera. She oversees laboratory escalations across clinical genomic operations with a focus on carrier screening, variant curation/interpretation, and data review. Dr. Dincer earned her doctorate in Genetics and Genomics from the Icahn School of Medicine at Mount Sinai and completed her clinical training in cytogenetics and molecular genetics at the same institution. Prior to joining Natera, she held a junior faculty appointment at Mount Sinai. Dr. Dincer’s clinical and research interests include advancing NGS-based diagnostics (WES/WGS), carrier screening, and cell-free DNA–based noninvasive prenatal testing with the overarching goal of utilizing these cutting-edge molecular technologies to provide accurate, efficient, equitable genetic testing and high-quality care.